Article Text

PDF
Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1
  1. J A McCaughan1,
  2. S M Holloway1,
  3. R Davidson2,
  4. W W K Lam1
  1. 1South East of Scotland Clinical Genetics Service, University of Edinburgh, Western General Hospital, Edinburgh, UK
  2. 2West of Scotland Clinical Genetics Service, Fergusson Smith Centre for Clinical Genetics, Yorkhill Hospitals, Glasgow, UK
  1. Correspondence to:
 Dr W W K Lam
 South East of Scotland Clinical Genetics Service, MMC Building, Western General Hospital, Crewe Road, Edinburgh EH4 2UX, UK; wayne.lam{at}ed.ac.uk

Abstract

A recent study, looking at the lifetime risk of developing malignant peripheral nerve sheath tumour (MPNST) in patients with neurofibromatosis type 1 (NF1), estimated the risk to be 8–13%. Prior to this, longitudinal studies had shown that patients with NF1 had a risk of 4–5% of developing MPNST, and cross-sectional studies had found that only 1–2% of patients with NF1 had MPNST. The aim of this study was to estimate the lifetime risk of MPNST in patients with NF1 in southern Scotland, using patient records obtained from the Edinburgh and Glasgow Genetic Units and Scottish Cancer Register. In the period 1993–2002, 14 patients with NF1 were diagnosed with MPNST in a population of 3.5 million. The lifetime risk of MPNST in the Scottish patients with NF1 was calculated to be 5.9–10.3%. This provides further evidence that patients with NF1 are at greater risk of developing MPNST than was previously estimated, and emphasises the importance of educating patients about suspicious symptoms, which may need an urgent medical opinion. The mean age at diagnosis of MPNST (p<0.05) and 5-year survival (p<0.01) were significantly lower in patients with NF1 than in unaffected individuals. This may be due to patients with NF1 presenting later, because the tumour is mistaken for a neurofibroma, or due to MPNST having a more aggressive course in NF1.

  • MPNST, malignant peripheral nerve sheath tumour
  • NF1, neurofibromatosis type 1
  • NIH, National Institute of Health
  • SCR, Scottish Cancer Register

Statistics from Altmetric.com

Footnotes

  • Published Online First 27 February 2007

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.